US HB6253 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 5-0)
Status: Introduced on March 12 2020 - 25% progression, died in committee
Action: 2020-03-12 - Referred to the Committee on Financial Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Financial Services Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 12 2020 - 25% progression, died in committee
Action: 2020-03-12 - Referred to the Committee on Financial Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Financial Services Committee
Text: Latest bill text (Introduced) [PDF]
Summary
(1) establishes an award for the successful development of a vaccine for the coronavirus (i.e., the virus that causes COVID-19), and (2) extends specified Securities and Exchange Commission (SEC) registration exemptions to issuers of securities responding to the COVID-19 outbreak. The bill provides appropriations for the purpose of awarding a prize to the creator of a vaccine that (1) reduces the incidence and mortality rate of COVID-19 by more than 50%, and (2) is affordable and widely available to the public. Additionally, an issuer of securities that is developing a coronavirus vaccine, researching or producing medical equipment related to COVID-19, or researching or producing technology related to preventing the spread of COVID-19 may qualify for an exemption from SEC registration requirements regardless of the size of the issuer's offers or sales. Furthermore, these issuers are not subject to joint and several liability for certain claims. The provisions set forth in this bill expire the earlier of (1) the date the prize is awarded, or (2) three years after enactment. The Government Accountability Office must report on the bill's effects.
Title
Crowdfunding to Combat the Coronavirus Act
Sponsors
Rep. Patrick McHenry [R-NC] | Rep. Ann Wagner [R-MO] | Rep. Garland Barr [R-KY] | Rep. Steve Stivers [R-OH] |
Rep. Bill Huizenga [R-MI] |
History
Date | Chamber | Action |
---|---|---|
2020-03-12 | House | Referred to the Committee on Financial Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2020-03-12 | House | Referred to the Committee on Financial Services, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2020-03-12 | House | Introduced in House |
Subjects
Cardiovascular and respiratory health
Congressional oversight
Educational technology and distance education
Emergency medical services and trauma care
Finance and financial sector
Financial services and investments
Government studies and investigations
Health promotion and preventive care
Health technology, devices, supplies
Immunology and vaccination
Infectious and parasitic diseases
Internet and video services
Research and development
Securities
Congressional oversight
Educational technology and distance education
Emergency medical services and trauma care
Finance and financial sector
Financial services and investments
Government studies and investigations
Health promotion and preventive care
Health technology, devices, supplies
Immunology and vaccination
Infectious and parasitic diseases
Internet and video services
Research and development
Securities
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/6253/all-info |
Text | https://www.congress.gov/116/bills/hr6253/BILLS-116hr6253ih.pdf |